Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis

OBJECTIVE: DNA methylation is the earliest and most studied epigenetic modification in cancer. The literature reported that the abnormal methylation level of multiple genes was associated with poor prognosis in ovarian cancer. However, due to a small sample size, the results reported in the literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Li-yuan, Chen, Chang-xian, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408028/
https://www.ncbi.nlm.nih.gov/pubmed/30813180
http://dx.doi.org/10.1097/MD.0000000000014588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408028/
https://www.ncbi.nlm.nih.gov/pubmed/30813180
http://dx.doi.org/10.1097/MD.0000000000014588

Ejemplares similares